Overview

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Losartan Potassium/Hydrochlorothiazide 100/25 mg tablet under fasted conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Hydrochlorothiazide
Losartan